Clinical Trial Update: FR901228 in Treating Patients With Previously Treated Unresectable Locally Advanced or Metastatic Colorectal Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial of romidepsin (FR901228) in patients with previously treated unresectable locally advanced or metastatic colorectal cancer has completed; results …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Romidepsin (romidepsin)

Snippet

Sponsor: SWOG Cancer Research Network | Conditions: Colorectal Cancer | Phase 2 | Status: COMPLETED